Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide add-on for apathy in Parkinson's disease
2017-003254-17Phase 4Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) and apathy comparing Safinamide add-on with Placebo add-on (2 arms). Primary endpoint: Change in Apathy Scale total score. Started Nov 2017; status: terminated.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)apathy
Beyond the preview
Go deeper on 2017-003254-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003254-17.